David A. Giljohann
Chief Executive Officer presso EVOQ Therapeutics, Inc.
Profilo
David A.
Giljohann holds the position of Chief Executive Officer of EVOQ Therapeutics, Inc.
In his past career he occupied the position of Chief Technology Officer of Exicure, Inc. and Chief Executive Officer & Director at Exicure Operating Co. (a subsidiary of Exicure, Inc.) and Founding Scientist at Aurasense LLC.
Dr. Giljohann received an undergraduate degree and a doctorate from Northwestern University.
Posizioni attive di David A. Giljohann
Società | Posizione | Inizio |
---|---|---|
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Chief Executive Officer | 09/01/2023 |
Precedenti posizioni note di David A. Giljohann
Società | Posizione | Fine |
---|---|---|
EXICURE, INC. | Chief Executive Officer | 10/12/2021 |
Aurasense LLC | Chief Tech/Sci/R&D Officer | 01/01/2009 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Chief Executive Officer | - |
Formazione di David A. Giljohann
Northwestern University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EXICURE, INC. | Health Technology |
Aziende private | 3 |
---|---|
Aurasense LLC | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Health Technology |